A well-traveled path

As we watch investors boost shares of Livongo to what we believe are unsustainable levels we harken back to the past and remember other times when Diabetic Investor stood alone in the wilderness. This is not the first nor likely will it the last time when we went against the tide. The question is will be right about Livongo or will we eat crow.

The first time this happened came after our very first ADA in New Orleans. Back then Diabetic Investor was a print publication and in an effort to boost awareness we actually had a booth in the . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.